Pantoprazole Sodium
Product Images NDC 21695-771

2 FDA label images from Rebel Distributors Corp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pantoprazole Sodium (NDC 21695-771). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (A81dc60e Af42 4d5a Ba21 865fec74ce05 01)

Structural Formula (A81dc60e Af42 4d5a Ba21 865fec74ce05 01)
Chemical structure of pantoprazole sodium hydrate showing the molecular arrangement including a substituted benzimidazole ring and sulfoxide group with 1.5 water molecules.*
FDA Label Image

Pantoprazole Sodium 40mg (A81dc60e Af42 4d5a Ba21 865fec74ce05 02)

Pantoprazole Sodium 40mg (A81dc60e Af42 4d5a Ba21 865fec74ce05 02)
Pantoprazole Sodium 40 mg delayed-release (DR) tablets label from Rebel Distributors Corp, NDC 21695-771-30. The label states each tablet contains Pantoprazole sodium equivalent to 40 mg of Pantoprazole. Packaging details include 30 tablets per bottle by Physician Partner, Thousand Oaks, CA. The label also indicates storage instructions and manufacturer information: Teva Pharmaceutical Industries Ltd., Jerusalem, Israel.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.